STUDY OF INPATIENT COMPLIANCE IN CPEIC HOSPITAL REGARDING CVS DISORDERS

http://dx.doi.org/10.31703/gpsr.2018(III-I).05      10.31703/gpsr.2018(III-I).05      Published : Dec 2018
Authored by : Hina Shoukat , Sobia Noreen , Saeed Ajwad Bukhari , Sameer Hassan

05 Pages : 32-50

References

  • Anand, P. M., Billmoria, A. R., ed,(1999). Hypertension. An International Monograph 2000. New Delhi. IJCP Group of Publications1- 17
  • Cheng, J. W. M., Kalis, M. M., Feifer, S. (2001) Patient-Reported Adherence to Guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Pharmacotherapy 21(7): 828-841.
  • Chobanian, A.V., Bakris, G. L., Black, H. R., et al. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560- 2572
  • Hashmi, S.K., Afridi, M.B., Abbas, K. Sajwani R. A., Saleheen, D., et al. (2007) Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan. PLoS ONE 2(3): e280
  • Kearney, P.M., Whelton, M. Reynolds, K. Muntner, P. Whelton, P.K., et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-23.
  • Mitchell, R. S., Kumar, V. Abbas, A. K., Fausto, N. (2007). Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. p. 345.
  • National Health Survey of Pakistan 1990-1994 (1998) Karachi, Pakistan: Pakistan Medical Research Council.
  • Nosé, M. Barbui, C. Gray, R. Tansella, M. (2003). Clinical interventions for treatment non- adherence in psychosis: meta-analysis. British Journal of Psychiatry 183 (3): 197-206.
  • Third World Network. Globalization and equitable access to essential drugs. http://www.twnside.org.sg/title/twr120c.htm
  • World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster (2004). The global burden of disease 2004 update. Geneva: WHO.
  • Youssef, R. M., Moubarak II. (2002) Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J 8: 4-5.
  • Anand, P. M., Billmoria, A. R., ed,(1999). Hypertension. An International Monograph 2000. New Delhi. IJCP Group of Publications1- 17
  • Cheng, J. W. M., Kalis, M. M., Feifer, S. (2001) Patient-Reported Adherence to Guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Pharmacotherapy 21(7): 828-841.
  • Chobanian, A.V., Bakris, G. L., Black, H. R., et al. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560- 2572
  • Hashmi, S.K., Afridi, M.B., Abbas, K. Sajwani R. A., Saleheen, D., et al. (2007) Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan. PLoS ONE 2(3): e280
  • Kearney, P.M., Whelton, M. Reynolds, K. Muntner, P. Whelton, P.K., et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-23.
  • Mitchell, R. S., Kumar, V. Abbas, A. K., Fausto, N. (2007). Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. p. 345.
  • National Health Survey of Pakistan 1990-1994 (1998) Karachi, Pakistan: Pakistan Medical Research Council.
  • Nosé, M. Barbui, C. Gray, R. Tansella, M. (2003). Clinical interventions for treatment non- adherence in psychosis: meta-analysis. British Journal of Psychiatry 183 (3): 197-206.
  • Third World Network. Globalization and equitable access to essential drugs. http://www.twnside.org.sg/title/twr120c.htm
  • World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster (2004). The global burden of disease 2004 update. Geneva: WHO.
  • Youssef, R. M., Moubarak II. (2002) Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J 8: 4-5.

Cite this article

    APA : Shoukat, H., Noreen, S., & Bukhari, S. A. (2018). Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders. Global Pharmaceutical Sciences Review, III(I), 32-50. https://doi.org/10.31703/gpsr.2018(III-I).05
    CHICAGO : Shoukat, Hina, Sobia Noreen, and Saeed Ajwad Bukhari. 2018. "Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders." Global Pharmaceutical Sciences Review, III (I): 32-50 doi: 10.31703/gpsr.2018(III-I).05
    HARVARD : SHOUKAT, H., NOREEN, S. & BUKHARI, S. A. 2018. Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders. Global Pharmaceutical Sciences Review, III, 32-50.
    MHRA : Shoukat, Hina, Sobia Noreen, and Saeed Ajwad Bukhari. 2018. "Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders." Global Pharmaceutical Sciences Review, III: 32-50
    MLA : Shoukat, Hina, Sobia Noreen, and Saeed Ajwad Bukhari. "Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders." Global Pharmaceutical Sciences Review, III.I (2018): 32-50 Print.
    OXFORD : Shoukat, Hina, Noreen, Sobia, and Bukhari, Saeed Ajwad (2018), "Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders", Global Pharmaceutical Sciences Review, III (I), 32-50
    TURABIAN : Shoukat, Hina, Sobia Noreen, and Saeed Ajwad Bukhari. "Study of In-Patient Compliance in CPEIC Hospital Regarding CVS Disorders." Global Pharmaceutical Sciences Review III, no. I (2018): 32-50. https://doi.org/10.31703/gpsr.2018(III-I).05